Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
5.00
+0.09 (1.83%)
At close: Jun 26, 2026, 4:00 PM EDT
4.900
-0.100 (-2.00%)
After-hours: Jun 26, 2026, 6:23 PM EDT
Aclaris Therapeutics Employees
As of December 31, 2025, Aclaris Therapeutics had 73 total employees, including 69 full-time and 4 part-time employees. The number of employees increased by 9 or 14.06% compared to the previous year.
Employees
73
Change (1Y)
9
Growth (1Y)
14.06%
Revenue / Employee
$114,616
Profits / Employee
-$954,274
Market Cap
698.32M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| Rigel Pharmaceuticals | 174 |
| Inventiva | 77 |
| SpyGlass Pharma | 68 |
| AgomAb Therapeutics NV | 62 |
| Oculis Holding AG | 60 |
| Candel Therapeutics | 55 |
| Immix Biopharma | 21 |
ACRS News
- 11 days ago - Aclaris Therapeutics management to meet with Oppenheimer - TheFly
- 23 days ago - Aclaris Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Aclaris Therapeutics Transcript: AGM 2026 - Transcripts
- 26 days ago - Aclaris Therapeutics initiated with an Outperform at LifeSci Capital - TheFly
- 4 weeks ago - Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Aclaris Therapeutics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Aclaris Therapeutics Slides: FY 2026 - Filings
- 7 weeks ago - Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference - GlobeNewsWire